AACR Project GENIE® functions as a nonprofit, contract research organization (CRO) wholly owned by the American Association for Cancer Research, that operates a unique research platform.
We collaborate with research leaders throughout the R&D lifecycle–from target discovery and trial design to post-market regulatory activities–delivering best-in-class real-world data (RWD) solutions.
AACR Project GENIE® is powered by two tightly integrated assets:
AACR Project GENIE Registry
The world’s largest open-access, pan-cancer clinico-genomic real-world data repository (289,000+ tumors and growing).
Delivers deeply curated, longitudinal molecular & clinical data suitable for exploratory science and regulatory engagements.
AACR Project GENIE Consortium
A legally-bound network of 19 premier academic cancer centers across North America, Europe, and Asia.
Provides prospective data, fit-for-purpose biospecimens, and turnkey infrastructure for international multi-site studies, ensuring speed and data quality.
Together, the AACR Project GENIE® Registry and Consortium form an oncology RWD ecosystem that powers precision medicine innovation.